Christoph Grohmann

1PUBLICATIONS
11CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Mar 13, 2021
Preclinical small molecule WEHI-7326 overcomes drug resistance and elicits response in patient-derived xenograft models of human treatment-refractory tumors.

Christoph Grohmann, Francesca Walker, Mark Devlin

Pageof 1

Frequent Collaborators

1 joint publications

François Vaillant

1 joint publications

Gwo-Yaw Ho

1 joint publications

Matthew J Wakefield

1 joint publications

Clare E Weeden

1 joint publications

Chin Wee Tan

1 joint publications

Gregor Ebert

1 joint publications

Michelle Haber

1 joint publications

Jamie I Fletcher

1 joint publications

Marie-Liesse Asselin-Labat

1 joint publications

Geoffrey J Lindeman

Frequent Collaborators

1 joint publications

François Vaillant

1 joint publications

Gwo-Yaw Ho

1 joint publications

Matthew J Wakefield

1 joint publications

Clare E Weeden

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

5.3K
See more related videos

Top Related Videos

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

5.3K
See more related videos